Caffeine for Excessive Daytime Somnolence in Parkinson's Disease

NCT00459420 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Excessive Daytime Somnolence

Interventions

DRUG: Caffeine 100-200 mg BID
DRUG: placebo

Sponsor

Ron Postuma

Collaborators

[object Object]
[object Object]